Coronapod: Why COVID antibody treatments may not be the answer
Nature Podcast
00:00
Monoclonal Antibodies - Is There Resistance?
There are some people who are quite concerned that if you start rolling out individual monoclonal annabody therapie s on a wide scale tat you're going to encourage the development of resistance. So that is a concern. There was an interesting development in that case, i guess, with one of the antabodies that had clinical trial results announced last week. And that particular annaboty targets a bit of a protein that tends to not mutate, tends to stay very stable.
Transcript
Play full episode
